Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study

被引:36
|
作者
Mindachew, Mesele [1 ]
Deribew, Amare [2 ]
Memiah, Peter [3 ]
Biadgilign, Sibhatu [2 ]
机构
[1] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Gen Publ Hlth, Jimma, Ethiopia
[2] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol, Jimma, Ethiopia
[3] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA
来源
关键词
Isoniazid preventive therapy; People Living with HIV; TB;
D O I
10.11604/pamj.2014.17.26.2641
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Isoniazid preventive therapy (IPT) reduces the risk of active TB. IPT is a key public health intervention for the prevention of TB among people living with HIV and has been recommended as part of a comprehensive HIV and AIDS care strategy. However, its implementation has been very slow and has been impeded by several barriers. Objective: The Objective of the study is to assess the perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings in Addis Ababa, Ethiopia in 2010. Methods: A qualitative study using a semi-structured interviewed guide was used for the in-depth interview. A total of 12 key informants including ART Nurse, counselors and coordinators found in four hospitals were included in the interview. Each session of the in-depth interview was recorded via audio tape and detailed notes. The interview was transcribed verbatim. The data was analyzed manually. Results: the findings revealed that poor patient adherence was a major factor; with the following issues cited as the reasons for poor adherence; forgetfulness; lack of understanding of condition and patient non- disclosure of HIV sero-status leading to insubstantial social support; underlying mental health issues resulting in missed or irregular patient appointments; weak patient/healthcare provider relationship due to limited quality interaction; lack of patient information, patient empowerment and proper counseling on IPT; and the deficient reinforcement by health officials and other stakeholders on the significance of IPT medication adherence as a critical for positive health outcomes. Conclusion: Uptake of the implementation of IPT is facing a challenge in resource limited settings. This recalled provision of training/capacity building and awareness creation mechanism for the health workers, facilitating disclosure and social support for the patients is recommended.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Effectiveness of a six-month Isoniazid as tuberculosis preventive therapy in people living with HIV in eritrea: A retrospective cohort study
    Russom, Mulugeta
    Stricker, Bruno
    Woldu, Henok G.
    Berhane, Araia
    Jeannetot, Daniel
    Verhamme, Katia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 209 - 210
  • [42] Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016)
    Maokola, Werner
    Ngowi, Bernard
    Lawson, Lovetti
    Robert, Masanja
    Mahande, Michael
    Todd, Jim
    Msuya, Sia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 562 - 567
  • [43] Assessment of Isoniazid Preventive Therapy Outcome Among People Living with HIV in a Referral Hospital, Northeast Ethiopia
    Mengesha, Yohannes
    Ahmed, Muhammed
    INTEGRATED PHARMACY RESEARCH AND PRACTICE, 2020, 9 : 127 - 133
  • [44] Use of Isoniazid Preventive Therapy for Tuberculosis Prophylaxis Among People Living With HIV/AIDS: A Review of the Literature
    Briggs, Melissa A.
    Emerson, Courtney
    Modi, Surbhi
    Taylor, Nicholas Kenji
    Date, Anand
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 : S297 - S305
  • [45] Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe
    Nyathi, Saziso
    Dlodlo, Riitta A.
    Satyanarayana, Srinath
    Takarinda, Kudakwashe C.
    Tweya, Hannock
    Hove, Sithokozile
    Matambo, Ronnie
    Mandewo, Winnie
    Nyathi, Khulamuzi
    Sibanda, Edwin
    Harries, Anthony D.
    PLOS ONE, 2019, 14 (10):
  • [46] Barriers to and Facilitators of Adherence to Antiretroviral Therapy Among People Living With HIV in Lao PDR: A Qualitative Study
    Portelli, Monique S.
    Tenni, Brigitte
    Kounnavong, Sengchanh
    Chanthivilay, Phetsavanh
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2015, 27 (02) : NP778 - NP788
  • [47] Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings
    Huerga, Helena
    Mueller, Yolanda
    Ferlazzo, Gabriella
    Mpala, Qhubekani
    Bevilacqua, Paolo
    Vasquez, Beatrice
    Mekiedje, Calorine Noel
    Ouattara, Ali
    Mchunu, Gugu
    Weyenga, Herman O.
    Varaine, Francis
    Bonnet, Maryline
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : e89 - e95
  • [48] Experiences of stigma in healthcare settings by people living with HIV in Ireland: a qualitative study
    Vaughan, Elena
    Power, Martin
    Sixsmith, Jane
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (09): : 1162 - 1167
  • [49] The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study
    Durovni, Betina
    Cavalcante, Solange C.
    Saraceni, Valeria
    Vellozo, Vitoria
    Israel, Giselle
    King, Bonnie S.
    Cohn, Silvia
    Efron, Anne
    Pacheco, Antonio G.
    Moulton, Lawrence H.
    Chaisson, Richard E.
    Golub, Jonathan E.
    AIDS, 2010, 24 : S49 - S56
  • [50] Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania
    Olivia F. Hunter
    Furaha Kyesi
    Amrit Kaur Ahluwalia
    Zeinabou Niamé Daffé
    Patricia Munseri
    C. Fordham von Reyn
    Lisa V. Adams
    BMC Infectious Diseases, 20